--
--(--)
--
--(--)
Expected P&L on Expiry
Key Stats
0.00DAY`S RANGE0.00
0.00
0.00
--
--
--
--
--
--
--
Pricing Model
--
--
--
--
--
--
About XERS20260417C7.5
Pharmaceutical
Xeris Biopharma Holdings, Inc., was incorporated in 2005 under the laws of the State of Delaware. The company is committed to building an innovative, self-sustaining, growth-oriented biopharmaceutical company dedicated to improving the lives of patients by developing and commercializing clinically meaningful products in a range of therapies. The company is uniquely positioned to achieve this with three commercial products and proprietary formulation science (XeriSol and XeriJect) to build partnerships and enhance product candidates.
